MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceuticals _ Orphan & Rare Diseases
Molecular Insight Pharmaceuticals, Inc
Finance & Acquisitions: Molecular Insights
IPO (2007)
Synta Pharmaceuticals
Parents
*Architects: BioPharmaceuticals_Inflammation, Allergy & Autoimmune
*Industry: Massachusetts
Companies: Merger Partners_(M&A)
IPO (2007)
Children
2016: Synta and Madrigal Announce Merger Agreement to Create Leading Cardiovascular-Metabolic Diseases and NASH Company
Cambridge, Massachusetts 02142
Diverse pipeline of novel, small-molecule drug candidates targeting major unmet needs in large therapeutic markets
Including chronic inflammatory diseases and cancers
Jumps
Dr Judah Folkman MD, Children's Hospital, Boston
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL)*